Nama's AI scorecard currently rates MetLife Buy (5.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is MET's P/E ratio?

MetLife trades at a trailing price-to-earnings ratio of 9.7.

When does MET report earnings?

MetLife's next scheduled report is on Feb 10, 2027. Analysts expect EPS of $2.62.

What is the MET price target?

The median analyst price target from 16 analysts is $110.00, with a range of $84.00 – $119.00.

Is MET Shariah compliant?

Nama's AAOIFI-style screen reads MetLife as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does MET pay a dividend?

Yes — MetLife's dividend yield is 2.4%.

Nama Insights

MetLife (MET)

Financial Services · Insurance Life · NYSE

S&P 500

MetLife (MET) is a Financial Services company in the Insurance Life industry. It has a market capitalization of $62.02B and a trailing price-to-earnings ratio of 9.7. Over the most recent reported fiscal year, revenue grew 7.9%. Nama's AI scorecard rates it Buy, 5.9 out of 10. On 12-month momentum it ranks in the leading band of its market.

AI scorecard

Buy · 5.9/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Leading · +26.1% over 12 months ex. last

Top 20% of its market on the past year's steady rise.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-7.9%

How far the last close sits under the highest price of the past five years.

Market cap	$62.02B
Trailing P/E	9.7
Price / book	2.3
Price / sales	0.8
FCF yield	—
Dividend yield	2.4%
Gross margin	23.9%
Operating margin	5.5%
Net margin	4.6%
Revenue growth (YoY)	+7.9%
Revenue growth (3-yr annual)	+3.9%
EPS growth (YoY)	+8.5%
FCF/share growth (YoY)	—
Beta	0.8
Exchange	NYSE
Sector	Financial Services
Industry	Insurance Life

MET earnings

Next report: Feb 10, 2027 (Q4 2026, EPS estimate $2.62). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 4, 2026	$2.78	$2.77	+0.4%	—
Q2 2026	Aug 5, 2026	$2.43	$2.29	+6.1%	$18.88B
Q1 2026	May 6, 2026	$2.42	$2.27	+6.6%	$18.62B
Q4 2025	Feb 4, 2026	$2.49	$2.34	+6.4%	$23.29B

MET analyst price target

Median target $110.00 from 16 analysts, ranging $84.00 – $119.00.

Insurance Life peers

Ticker	Company	Market cap	P/E
MFC	Manulife Financial	$71.43B	13.6
AFL	Aflac	$61.49B	16.5
PRU	Prudential Financial	$40.90B	8.1
PUK	Prudential	$30.28B	—
UNM	Unum Group	$11.89B	9.1
GL	Globe Life	$11.86B	10.3
PRI	Primerica	$8.86B	11.5
JXN	Jackson Financial	$8.70B	5.0

Explore live MET data on Nama Insights →

Recent Congressional trades

MetLife trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Sep 12, 2025
Thomas R Carper	Senate	Buy	$1,001 - $15,000	—
John Hoeven	Senate	Buy	$50,001 - $100,000	—

MET FAQ

Is MET a buy?: Nama's AI scorecard currently rates MetLife Buy (5.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is MET's P/E ratio?: MetLife trades at a trailing price-to-earnings ratio of 9.7.
When does MET report earnings?: MetLife's next scheduled report is on Feb 10, 2027. Analysts expect EPS of $2.62.
What is the MET price target?: The median analyst price target from 16 analysts is $110.00, with a range of $84.00 – $119.00.
Is MET Shariah compliant?: Nama's AAOIFI-style screen reads MetLife as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does MET pay a dividend?: Yes — MetLife's dividend yield is 2.4%.